Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Seres Therapeutics Inc (NASDAQ: MCRB) was $0.91 for the day, up 7.36% from the previous closing price of $0.84. In other words, the price has increased by $7.36 from its previous closing price. On the day, 1.52 million shares were traded. MCRB stock price reached its highest trading level at $0.91 during the session, while it also had its lowest trading level at $0.8242.
Ratios:
Our analysis of MCRB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.12 and its Current Ratio is at 1.12. In the meantime, Its Debt-to-Equity ratio is 3.91 whereas as Long-Term Debt/Eq ratio is at 3.56.
On April 21, 2023, JP Morgan started tracking the stock assigning a Neutral rating and target price of $7.JP Morgan initiated its Neutral rating on April 21, 2023, with a $7 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 18 ’24 when DesRosier Thomas sold 878 shares for $0.54 per share. The transaction valued at 475 led to the insider holds 135,192 shares of the business.
von Moltke Lisa sold 977 shares of MCRB for $528 on Nov 18 ’24. The insider now owns 32,415 shares after completing the transaction at $0.54 per share. On Nov 18 ’24, another insider, Shaff Eric D., who serves as the CEO and President of the company, sold 2,505 shares for $0.54 each. As a result, the insider received 1,355 and left with 170,389 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MCRB now has a Market Capitalization of 154586176 and an Enterprise Value of 149054544. For the stock, the TTM Price-to-Sale (P/S) ratio is 2766.23 while its Price-to-Book (P/B) ratio in mrq is 6.44. Its current Enterprise Value per Revenue stands at 1.18 whereas that against EBITDA is -4.084.
Stock Price History:
Over the past 52 weeks, MCRB has reached a high of $2.05, while it has fallen to a 52-week low of $0.54. The 50-Day Moving Average of the stock is 11.78%, while the 200-Day Moving Average is calculated to be 2.48%.
Shares Statistics:
MCRB traded an average of 2.80M shares per day over the past three months and 1853480 shares per day over the past ten days. A total of 170.20M shares are outstanding, with a floating share count of 124.81M. Insiders hold about 26.90% of the company’s shares, while institutions hold 23.58% stake in the company. Shares short for MCRB as of 1734048000 were 19613483 with a Short Ratio of 7.00, compared to 1731628800 on 16235306. Therefore, it implies a Short% of Shares Outstanding of 19613483 and a Short% of Float of 15.370000000000001.
